Login to My NLA Account
Title: Foundations of Lipidology

Ancillary Course Info

The NLA's Foundations of Lipidology course, formerly Lipid Academy, provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice, and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

The Foundations of Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

 

2023 Course Dates:

September 7-8, 2023
Scottsdale, AZ

To register Click Here

Course Curriculum

  • Lipids, Lipoproteins and Atherosclerosis
  • Landmark Clinical Trials
  • Dyslipidemia and Inherited Lipid Abnormalities
  • Pharmacologic Therapies
  • Therapeutic Lifestyle Changes
  • Specific Populations Diagnosis and Therapeutic Considerations
  • Overview of Clinical Guidelines in Lipid Management
  • Challenging Patient Cases   

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians seeking to develop an expertise in clinical Lipidology.

Pricing*
Member cost: $550
Non-Member cost: $950
Trainee cost: $0

*Pricing subject to change

At the conclusion of this activity, participants should be able to:

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Explain the pathogenesis of atherosclerosis, including the role of inflammation;
  • Describe the functions and sources of cholesterol and triglycerides including the role of lipoproteins in atherosclerosis;
  • Review basic principles of statistics in clinical trials;
  • Discuss key clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention;
  • Appraise clinical trial design and methods in published literature;
  • Recognize the role of drug therapy in the management of dyslipidemia;
  • Review the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of dyslipidemia;
  • Council patients on dietary recommendation for lipid management;
  • Recognize the importance of lifestyle modification in the reduction of cardiometabolic risk;
  • Compose a treatment plan for patients with complex lipid disorders;
  • Describe treatment approaches for dyslipidemia in specific populations based on age, gender, ethnicity, and cultural variable;
  • Discuss current guidelines for the management and treatment of patients with dyslipidemia;
  • Identify primary and secondary causes of dyslipidemia;
  • Compose a treatment plan for the management of dyslipidemia in specific populations;
  • Compose a treatment plan for reducing risk of CVD in patients with dyslipidemia.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

The National Lipid Association is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this Live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 12.25 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.


Pharmacists

UAN JA0007192-0000-23-004-L01-P (Application)
This activity has been approved for 12.25 contact hours (1.225 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 12.25.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/ claimed credit form at www.lipid.org/cme.

For Pharmacists:
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Disclosure Statement
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Commercial Support

Full notification of commercial support will be provided in the activity materials.

Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA

Clinical Scientist
Midwest Biomedical Research
Addison, IL
Adjunct Faculty
Kasiska Division of Health Science, Idaho State University
Pocatello, ID 
Joseph J. Saseen, PharmD, CLS, FNLA

Chair
Professor and Vice Chair
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Aurora, CO
Daniel E. Soffer, MD, FNLA

Chair
President, National Lipid Association
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA
Ann Liebeskind, MD, FNLA

Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor
University of Wisconsin
School of Medicine and Public Health
Madison, WI

2023 Foundations of Lipidology Course - Scottsdale

 

Thursday, September 7, 2023

Day 1

7:00 - 7:30 AM Registration & Breakfast

Add

7:30 AM - 7:45 AM Program Overview Course Chairs
7:45 AM - 8:45 AM Atherosclerosis, Lipids and Lipoproteins, Atherogenic Dyslipidemia Daniel E. Soffer, MD, FNLA
8:45 AM - 8:55 AM Break
8:55 AM - 10:25 AM Current Lifestyle Recommendations Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
10:25 AM - 10:40 AM Break
10:40 AM - 11:40 AM Pharmacologic Therapies Joseph J. Saseen, PharmD, CLS, FNLA
11:40 AM - 12:15 PM Lunch
12:15 PM - 1:15 PM Pharmacologic Therapies - Continued Joseph J. Saseen, PharmD, CLS, FNLA
1:15 PM - 1:25 PM Break
1:25 PM - 2:25 PM Landmark Clinical Trials Joseph J. Saseen, PharmD, CLS, FNLA
2:25 PM - 2:40 PM Break
2:40 PM - 3:40 PM Overview of Clinical Guidelines in Lipid Management Ann Liebeskind, MD, FNLA
3:40 PM - 3:50 PM Break
3:50 PM - 5:00 PM Dyslipidemia and Inherited Lipid Disorders Daniel E. Soffer, MD, FNLA

Add

Friday, September 8, 2023

Day 2

7:00 - 7:30 AM Breakfast

Add

7:30 AM - 7:35 AM Day Overview Course Chairs
7:35 AM - 8:35 AM Lipid Management of Specific Populations Ann Liebeskind, MD, FNLA
8:35 AM - 8:45 AM Break
8:45 AM - 9:45 AM Lipid Management of Specific Populations - Continued Ann Liebeskind, MD, FNLA
9:45 AM - 9:55 AM Break
9:55 AM - 10:25 PM Challenging Patient Case 1 Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, Joseph J. Saseen, PharmD, CLS, FNLA, Daniel E. Soffer, MD
10:25 PM - 10:55 PM Challenging Patient Case 2 Daniel E. Soffer, MD, FNLA, Joseph J. Saseen, PharmD, CLS, FNLA, Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, & Ann Liebeskind, MD, FNLA
10:55 AM - 11:25 AM Challenging Patient Case 3 Joseph J. Saseen, PharmD, CLS, FNLA, Daniel E. Soffer, MD, FNLA, Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, & Ann Liebeskind, MD, FNLA
11:25 AM - 11:55 AM Challenging Patient Case 4 Ann Liebeskind, MD, FNLA, Daniel E. Soffer, MD, FNLA, Joseph J. Saseen, PharmD, CLS, FNLA, & Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
11:55 AM - 12:00 PM Wrap-up

Add

12:00 - 12:30 PM Lunch

Add

Add